Skip to content

A Multicenter Study on Predicting Fetal Lung Development and Prognosis of Congenital Diaphragmatic Hernia Based on Fetal Lung MRI Radiomics

A Multicenter Study on Predicting Fetal Lung Development and Prognosis of Congenital Diaphragmatic Hernia Based on Fetal Lung MRI Radiomics

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124757
Enrollment
Unknown
Registered
2026-05-17
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Diaphragmatic Hernia

Interventions

CDH group:None
Control group (normal fetus group):None

Sponsors

Chongqing Health Center for Women and Children
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the experimental group: (1) singleton pregnancy; (2) Confirmed as CDH by prenatal ultrasound or MRI; (3) Have complete fetal MRI examination data; 2. Inclusion criteria for the control group: (1) singleton pregnancy; (2) Gestational age: 260,000-370,000 weeks; (3) Prenatal MRI examination showed no abnormal lung development imaging manifestations. (4) The postpartum Apgar score is normal; (5) There were no abnormal clinical manifestations of the respiratory system after birth.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for the study group (CDH group): (1) Presence of other major congenital structural anomalies; (2) Incomplete clinical or imaging data; (3) Pregnancy termination or miscarriage, or withdrawal of treatment after birth. 2. Exclusion criteria for the control group: (1) Any fetal structural anomaly or suspected anomaly; (2) Significant maternal comorbidities during pregnancy (e.g., gestational diabetes mellitus, gestational hypertension); (3) Severe respiratory problems requiring intervention in the early postnatal period; (4) Missing data or suboptimal MRI image quality.

Design outcomes

Primary

MeasureTime frame
Discharge survival status (alive/dead);

Secondary

MeasureTime frame
Pulmonary hypertension;Duration of mechanical ventilation (days);Length of hospital stay (days);Need for respiratory support at discharge (yes/no);

Countries

China

Contacts

Public ContactYang Qiaoli

Chongqing Health Center for Women and Children

373038595@qq.com+86 23 60354434

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026